© 2005 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Medroxyprogesterone Acetate and Metastases: Of Mice and (Wo)Men
Correspondence to: V. Craig Jordan, OBE, PhD, DSc, Vice President and Research Director for Medical Sciences, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111 (e-mail: v.craig.jordan@fccc.edu).
| The first 10% of the full text of this article appears below. |
Chambers raises an interesting argument [based on her recent publications noted in (1)] about treating patients after metastatic spread. In fact, the comments illustrate that the implementation of clinical treatment strategies, translational research, and the conduct of cancer cell biology can each be separate worlds divided
Related Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2005 97: 1225.
This article has been cited by other articles:
![]() |
V. C. Jordan RESPONSE: Re: Medroxyprogesterone Acetate and Metastases: Of Mice and (Wo)Men J Natl Cancer Inst, August 17, 2005; 97(16): 1225 - 1226. [Full Text] [PDF] |
||||
